放射介入治疗应用在肝癌治疗中的临床疗效

Clinical efficacy of interventional radiology treatment on primary hepatic carcinoma

目的对放射介入治疗应用在肝癌中的临床疗效进行观察分析。方法选取我院2013年6月至2014年6月收治的原发性肝癌患者112例作为本次研究的对象,所有患者均给予肝动脉化疗栓塞介入治疗,观察患者的临床治疗效果。结果巨块型肝癌患者治疗有效率为76.4%,弥漫型患者有效率为89.7%,结节型患者有效率为72.2%,治疗总有效率为80.4%。弥漫型患者有效率高于其他类型患者(P<0.05)。患者18个月后的生存率为75.0%。19例出现不良反应。结论肝动脉化疗栓塞介入治疗原发性肝癌患者的效果较好,操作简便,可有效延长患者的生存期,值得在临床推广应用。

Objective To investigate the clinical efficacy of interventional radiology treatment on primary hepatic carcinoma. Methods One hundred and twelve cases of patients with primary hepatic carcinoma admitted in our hospital from June 2013 to June 2014 were selected as the experimental subjects in this study. All the patients were treated with hepatic artery chemotherapy and interventional embolization treatment, the therapeutic effect was observed. Results The therapeutic effective rate in patients with massive hepatocellular carcinoma was 76.4%, the therapeutic effective rate in patients with diffuse hepatocellular carcinoma was 89.7%, the therapeutic effective rate in patients with nodular melanoma hepatocellular carcinoma was 72.2%, the overall treatment efficiency was 80.4%. The effective rate of patients with diffuse hepatocellular carcinom were higher than that of other types of patients （P〈0.05）. After 18 months follow-up, the survival rate was 75.0%,and adverse reactions occurred in 19 cases of patients. Conclusion The hepatic artery chemotherapy and interventional embolization treatment has a great effect in patients with primary hepatic carcinoma, and is easy to operate. It can effectively prolong the survival of patients and is worth to be popularized and applied in clinic.